Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications

Thursday, October 4th, 2018

6:00pm ~ Registration and dinner

6:30pm - 7:45pm ~ Education Program

*Buffet Dinner will be provided*


Maggiano's Little Italy at Park Square

4 Columbus Avenue

Boston, MA 02116

Capri-Medici Room


Hosted by

Boston Oncology Nursing Society Chapter

 

This 1.25-hour session will include 5 topic modules focused on the management of ER-positive mBC. Each module will employ an identical format and feature discussion of cases from the faculty members selected to depict common scenarios encountered in clinical practice (newly diagnosed ER-positive mBC, disease progression on an adjuvant aromatase inhibitor, progression on CDK4/6 inhibitor with endocrine therapy, et cetera). Topics addressed during the session will include the following:

~ Module 1 ~ Estrogen and Progesterone Receptors; Clinical Use of Endocrine Treatment

~ Module 2 ~ First-Line Endocrine Therapy for Metastatic Disease: Role of CDK4/6 Inhibitors

~ Module 3 ~ Second-Line Endocrine Therapy for Metastatic Disease: Role of mTOR Inhibitors

~ Module 4 ~ New Approaches Under Investigation

~ Module 5 ~ Assessing and Optimizing Treatment Adherence


38 views0 comments